UConn scientist working on a new way to repair knees

20180516 Cato Laurencin regrow ACL 2013.JPG

I also came across the following

UConn scientist working on a new way to repair knees via ctmirror

Aug 22, 2013

https://ctmirror.org/2013/08/22/uconn-scientist-working-new-way-repair-knees

There’s a clinical trial underway to test a new type of ligament Laurencin invented, which has already regenerated ACL tissue in animals. If successful, the next step would likely be a large clinical trial in the U.S. and seeking approval from the FDA to put the ligament into widespread use.

It’s part of the development of a field Laurencin calls regenerative engineering

Success of the surgery is often described in terms of how common it is for patients to return to sports; studies have offered varied pictures. Some have found 90% of patients return to sports 1 year after the surgery, others show the rate is closer to 50 - 70%.

In a patient with a torn ACL, the stump that remains contains a storehouse of nutrients and stemcells, which have the potential to grow into new tissue. Laurencin’s method involves using those cells and others that are already present, by placing a specially engineered “matrix” where the ligament should be. Cells can attach to it, creating new tissue.

“In many ways, we utilize the patient’s own body as a bioreactor, if you will, to be able to make the tissue,”

It took years to create the matrix, which had to have the right mechanical and chemical properties to allow for regeneration. Laurencin worked on it with James Cooper, a former PhD student now a prof at Rensselaer Polytechnic Institute in New York.  The matrix, the L-C Ligament, is named for Laurencin and Cooper.

Research in rabbits showed that the matrix could regenerate an ACL. For the past 2 years, it was studied in sheep. The clinical trial in humans began in the Netherlands in June.

The L-C Ligament is designed to provide support for the knee as soon as it’s implanted. It takes between a year and 18 months to fully regenerate an ACL, Laurencin said.

The device was recently patented; patent-holder is Soft Tissue Regeneration, a New Haven-based co. Laurencin co-founded. The co. has received funding from the state’s Connecticut Innovations, which gives the state a share of the co.